Singapore markets closed

BriaCell Therapeutics Corp. (BCTXW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3428+0.0125 (+3.78%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/07/2023
31/07/2022
31/07/2021
31/07/2020
31/07/2019
Cash flows from operating activities
Net income
-5,996
-20,302
-26,839
-13,816
-4,025
-
Depreciation & amortisation
15.271
15.271
15.272
15.256
15.255
-
Stock-based compensation
1,960
2,194
3,075
1,968
1.686
-
Change in working capital
1,813
-3,532
-391.292
-2,282
2,671
-
Accounts payable
5,427
660.459
249.164
-1,406
-
-
Other working capital
-31,009
-23,745
-12,484
-7,750
-1,266
-
Other non-cash items
-
-
-2.409
1,876
70.581
-342.357
Net cash provided by operating activities
-31,009
-23,745
-12,484
-7,750
-1,266
-
Cash flows from investing activities
Net cash used for investing activities
-
-
-
0
0
1,092
Cash flows from financing activities
Debt repayment
-
-
0
-546.108
-388.733
-95.678
Common stock issued
-
4,000
0
51,622
1,152
-
Common stock repurchased
0
-47.294
-10,172
0
-
-
Other financing activities
-
-
-80.693
-
-
-89.3895
Net cash used provided by (used for) financing activities
4,000
3,954
-3,743
64,998
1,174
-
Net change in cash
-27,234
-19,791
-16,227
57,247
-91.834
-
Cash at beginning of period
28,170
41,042
57,269
21.249
157.034
-
Cash at end of period
935.694
21,251
41,042
57,269
21.249
-
Free cash flow
Operating cash flow
-31,009
-23,745
-12,484
-7,750
-1,266
-
Free cash flow
-31,009
-23,745
-12,484
-7,750
-1,266
-